Related Articles
Platinum‑based chemotherapy in triple‑negative breast cancer: A meta‑analysis
PD‑1/PD‑L1 inhibitor‑based immunotherapy in locally advanced or metastatic triple‑negative breast cancer: A meta‑analysis
Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis
Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR‑TKI treatment in advanced NSCLC
Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis